Treating CML

Bfore-

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Templates to send to your MP

Submitted by admin on Fri, 25/09/2015 - 5:13pm

Please consider adapting one or more of the letters contained in this Microsoft Word template file and sending it to your MP

Read more about Templates to send to your MP

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

Submitted by admin on Tue, 04/08/2015 - 7:29pm

Nature:

International Weekly Journal of Science

Read more about Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation
Log in or register to post comments
Email this page

Overview CML 1st line, 2nd line, managing resistance- Michael Mauro

Submitted by admin on Mon, 03/08/2015 - 5:52pm

Read more about Overview CML 1st line, 2nd line, managing resistance- Michael Mauro

Treatment-free remission, stop trials, predictors for stopping treatment- Andreas Hochhaus

Submitted by admin on Mon, 03/08/2015 - 5:12pm

Read more about Treatment-free remission, stop trials, predictors for stopping treatment- Andreas Hochhaus

The patient perspective on treatment-free remission, including support needs- Pat Elliott

Submitted by admin on Mon, 03/08/2015 - 5:10pm

Read more about The patient perspective on treatment-free remission, including support needs- Pat Elliott

Panel discussion: The psychology of stopping treatment

Submitted by admin on Mon, 03/08/2015 - 5:07pm

Read more about Panel discussion: The psychology of stopping treatment

Beyond TKIs - addressing different pathways (Arnon Nagler)

Submitted by admin on Mon, 03/08/2015 - 4:22pm

Read more about Beyond TKIs - addressing different pathways (Arnon Nagler)

"Do we all do it in the same way?" EBMT documentary

Submitted by admin on Mon, 03/08/2015 - 4:15pm

Read more about "Do we all do it in the same way?" EBMT documentary

DASISION

A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML

You are here